← Back to Bill Feed
FederalIn Committee

Prohibiting Abortion Industry’s Lucrative Loopholes Act

Introduced Jan 24, 2025 · Last action Jan 24, 2025 Referred to the House Committee on Energy and Commerce.

Track this bill

Save bills and get alerts when status changes.

Sign in to saved bills.

Summary

This legislation is called the Prohibiting Abortion Industry’s Lucrative Loopholes Act. Referred to the House Committee on Energy and Commerce.

Full bill text

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 727 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
                                H. R. 727

To amend title IV of the Public Health Service Act to prohibit sale or
              transactions relating to human fetal tissue.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 24, 2025

Mr. Scott Franklin of Florida (for himself, Mr. Weber of Texas, Ms. Van
 Duyne, Mr. Gosar, Mr. Self, Mr. Rogers of Kentucky, Mr. Ellzey, Mrs.
Miller of Illinois, Mr. Babin, Mr. Rutherford, Mr. Webster of Florida,
and Mr. Moolenaar) introduced the following bill; which was referred to
                  the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

To amend title IV of the Public Health Service Act to prohibit sale or
              transactions relating to human fetal tissue.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prohibiting Abortion Industry's
Lucrative Loopholes Act''.

SEC. 2. PROHIBITING SALE OR TRANSACTIONS RELATING TO HUMAN FETAL
              TISSUE.

    Section 498B(e) of the Public Health Service Act (42 U.S.C. 289g-
2(e)) is amended by striking paragraph (3) and inserting the following
new paragraph:
            ``(3) The term `valuable consideration' includes--
                    ``(A) any payment made or debt incurred;
                    ``(B) any gift, honorarium, or recognition of value
                bestowed;
                    ``(C) any price, charge, or fee which is waived,
                forgiven, reduced, or indefinitely delayed;
                    ``(D) any loan or debt which is canceled or
                otherwise forgiven;
                    ``(E) the transfer of any item from one person to
                another or provision of any service or granting of any
                opportunity for which a charge is customarily made,
                without charge or for a reduced charge; and
                    ``(F) any payments associated with the
                transportation, implantation, processing, preservation,
                quality control, or storage of human fetal tissue.''.
                                 <all>

Official legislative text sourced from the public record (cached on CivicsHQ).

Official source

View the original bill, actions, and full legislative record on Congress.gov.

View on Congress.govopen_in_new

Status

In Committee

  1. 1Introduced
  2. 2Committee
  3. 3Floor
  4. 4Passed
  5. 5Signed

Timeline reflects current normalized status only. Full action history is not yet stored in the API.

Votes

Voting records are not yet available for this bill.